Claustrophobia
Claustrophobia is the irrational fear of confined spaces.
Some people with claustrophobia experience mild anxiety when in a confined space, while others have severe anxiety or a panic attack. The most common experience is a feeling or fear of losing control.
Cluster Number:
Wiki Number: W043
Diagnosis: Claustrophobia
US Patients:
World Patients: 5-10%
Sex Ratio:
Age Onset:
Brain Area: Smaller amygdala, fight-flight response
Symptoms: fear confined spaces: elevators, windowless rooms, hotel rooms, small cars, tight-necked clothing, MRI machine
Progression: may result in severe panic attacks
Causes: fear of suffocation-release of adrenaline for an autonomic response; fear of restriction
Medications: None listed.
Therapies: 30%- cognitive therapy, convincing that the situation was not dangerous; exposure, 75%; virtual reality
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Cyberchondria, Covid-19 phobia, and well-being: a relational study on teachersby Neşe Karakaş on June 29, 2022
CONCLUSIONS: The study results show that increasing levels of cyberchondria trigger Covid-19 phobias in teachers during the Covid-19 pandemic and negatively affect their well-being. This descriptive study can help understand the risk group for cyberchondria, the influencing factors, and the health and economic consequences, and identify strategies for effective combating with cyberchondria.
- Fear of Pain as a Predictor for Postoperative Pain Intensity among the Patients Undergoing Thoracoscopic Surgeryby Yang Luo on June 27, 2022
CONCLUSIONS: Both trait FOP and state FOP were associated with higher postoperative pain reports after thoracic surgery. Trait FOP influences postoperative pain through the mediating effect of state FOP.
- Efficacy and safety studies review of Teraligen usage in psychiatric practice and general medicineby A A Shmilovich on June 27, 2022
CONCLUSION: According to the authors, the main effect of the «small» neuroleptic/antipsychotic Alimemazine (Teraligen ) is primarily aimed at pathological anxiety and affective instability. Its use is possible in various age groups, as it has a fairly high safety. In addition, like other «small» neuroleptics/antipsychotics with a predominantly sedative effect, the drug can be used to correct neuroleptics-prolongs side effects with dominant manifestations in the form of anxiety, irritability and...
- Childhood trauma and its impact on depressive and anxiety symptomatology in adulthood: A 6-year longitudinal studyby Erika Kuzminskaite on June 27, 2022
CONCLUSIONS: CT is a risk factor for depressive and anxiety symptomatology across all dimensions and enduring over multiple years. Screening for CT is essential to identify individuals at risk for more severe and chronic manifestations of affective disorders.